Thanks for that Greg .. a quickie summary outline on the issue re DNDN ... and the projected forecast revenue downgrades
... the treatment @$93K for provenge ... is too expensive a bill for ' smaller medical practices to carry ... and they have issues with getting paid by Medical cover (reimbursed)
... and hence Provenge has not had the take up it had forecast ... by smaller medical practices ... even though it cant keep up with current production, apparently ...
it is a 'bill paying ' thing ... not the product itself .. which is all good ... and hopefully should get sorted out
Thanks for that Greg .. a quickie summary outline on the issue...
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
34.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $501.1M | |||
| Open | High | Low | Value | Volume |
| 34.5¢ | 34.8¢ | 33.5¢ | $119.2K | 347.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 22 | 111885 | 34.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 34.5¢ | 135312 | 16 |
View Market Depth
| Last trade - 12.30pm 29/07/2024 (20 minute delay) ? |
| IMM (ASX) Chart |